To further explore coding of dementia and other types of brain disorders take our HIAlearn course Encephalopathy, Altered Mental Status, Dementia and Delirium Coding
It has never been approved, so it cannot be in "shortage," so there is no legal basis for compounding
And, so far, while quality and safety inspections and enforcement typical among compounders are occurring with compounders of GLP-1 products, we have not seen evidence publicly that the FDA is taking action specifically against the practice of compounding GLP-1 products that are no longer in shortage as products that are essentially a copy of the FDA-approved products
However, recent FDA actions on BPC-157 and other peptides have sent shockwaves through the peptide community
One of the most common mistakes involves reporting the medication code without reporting the administration code when separate reporting is appropriate and supported by documentation